Physician profile
Amy Dunbar
NPI 1891866364
$1,114.85
in general payments reported to CMS, 2019-2025
24 companies · $175 in 2025
The $175 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $33.10 · 2020: $41.81 · 2021: $108 · 2022: $421 · 2023: $293 · 2024: $43.63 · 2025: $175.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $512.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $511.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $175.98 | 2020-2025 | Liletta, Lo Loestrin Fe, Orilissa |
| Hologic Sales and Service, LLC | $126.55 | 2022-2025 | Thinprep 2000 Processor, Aptima, Third Wave |
| Myovant Sciences INC. | $125.79 | 2021-2022 | |
| Mayne Pharma Commercial LLC | $80.10 | 2021-2022 | |
| Exeltis, USA INC. | $64.54 | 2020-2023 | Slynd |
| Organon LLC | $62.95 | 2021-2025 | Nexplanon, Jada System |
| Sumitomo Pharma America, INC. | $53.29 | 2023 | Myfembree |
| Astellas Pharma US INC | $51.10 | 2023 | Veozah |
| Agile Therapeutics, INC. | $35.84 | 2022 | |
| Coopersurgical, INC. | $35.29 | 2022-2023 | Paragard T 380a |
| Axsome Therapeutics, INC. | $33.00 | 2025 | Symbravo |
| Bayer Healthcare Pharmaceuticals INC. | $32.87 | 2022-2023 | |
| Minerva Surgical, INC | $29.83 | 2022-2023 | |
| Cumberland Pharmaceuticals, INC. | $26.28 | 2022-2023 | Caldolor |
| Avion Pharmaceuticals | $24.56 | 2020-2021 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $21.74 | 2025 | Dexcom G6 Transmitter |
| Novo Nordisk INC | $19.68 | 2022 | |
| Intuitive Surgical, INC. | $19.36 | 2022 | |
| Merck Sharp & Dohme LLC | $19.14 | 2019 | |
| Mylan Pharmaceuticals INC. | $18.60 | 2021 | |
| Tris Pharma INC | $16.58 | 2025 | Dyanavel Xr |
| Vertex Pharmaceuticals Incorporated | $16.10 | 2025 | |
| Lupin INC. | $13.96 | 2019 | |
| Evofem Biosciences, INC. | $11.72 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Dunbar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.